Picture Kentro Design Is Key to Your Success Berlin 650x100px

Person › Details

Ian Garland (Vernalis plc (LSE: VER, Nasdaq: VNLS))

Garland, Ian (Vernalis 200812– CEO before Acambis CEO + Arrow Therapeutics CFO + Celltech Pharmaceuticals Inc)

	Organisation	Vernalis plc (LSE: VER, Nasdaq: VNLS)
	Group	Vernalis (Group)
	Former/major organisation	Acambis plc (LSE: ACM)
	Today	Acambis (Group)
	Group	Sanofi (Group) [since May 2011]
	Product	pharmaceutical

Record changed: 2017-03-10

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for Ian Garland

[1] Servier. (3/6/17). "Press Release: Vernalis plc and Servier Enter into a New Drug Discovery Collaboration Strengthening Their Existing Partnership"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]